 Whole-body lipolysis triglyceride-fatty acid cycling cachectic patients esophageal cancer Whole-body lipolytic rates rate triglyceride-fatty acid cycling reesterification fatty acids lipolysis stable isotopic tracers basal state beta-adrenergic blockade propranolol infusion cachectic patients squamous cell carcinoma esophagus cachectic cancer-free nutritionally-matched control patients healthy volunteers energy expenditure plasma catecholamines normal groups basal rate glycerol appearance blood patients cancer similar controls normal-weight volunteers antilipolytic effect propranolol rate triglyceride-fatty acid cycling patients cancer similar cachectic control group normal-weight volunteers differences significant variability data increase lipolysis triglyceride-fatty acid cycling unstressed cachectic patients esophageal cancer due alterations nutritional status presence tumor beta-adrenergic activity important contributor stimulation lipolysis